Skip Navigation


BJA Advance Access originally published online on May 19, 2009
British Journal of Anaesthesia 2009 103(2):220-225; doi:10.1093/bja/aep108
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
103/2/220    most recent
aep108v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Robinson, R. L.
Right arrow Articles by Shaw, M.-A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, R. L.
Right arrow Articles by Shaw, M.-A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author [2009]. Published by Oxford University Press on behalf of The Board of Directors of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournal.org

Epigenetic allele silencing and variable penetrance of malignant hyperthermia susceptibility

R. L. Robinson1, D. Carpenter1, P. J. Halsall1, D. E. Iles2, P. Booms1,2, D. Steele3, P. M. Hopkins1,*,{dagger} and M.-A. Shaw2,{dagger}

1 MH Investigation Unit, Academic Unit of Anaesthesia, St James’s University Hospital, Leeds LS9 7TF, UK
2 Institute of Integrative and Comparative Biology, Faculty of Biological Sciences, L C Miall Building
3 Institute of Membrane and Systems Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK

* Corresponding author. E-mail: p.m.hopkins{at}leeds.ac.uk

Background: Tissue-specific monoallelic silencing of the RYR1 gene has been proposed as an explanation for variable penetrance of dominant RYR1 mutations in malignant hyperthermia (MH). We examined the hypothesis that monoallelic silencing could explain the inheritance of an MH discordant phenotype in some instances.

Methods: We analysed parent–offspring transmission data from MH kindreds to assess whether there was any deviation from the expected autosomal dominant Mendelian inheritance pattern. We also evaluated informative single-nucleotide polymorphism (SNP) genotypes in a cohort of unrelated MH patients using genomic DNA (gDNA, prepared from leucocytes) and coding DNA (cDNA, prepared from skeletal muscle). Finally, we examined the segregation of specific mutations at the gDNA and cDNA level within MH families where positive RYR1 gDNA genotype/normal MH phenotype discordance had been observed.

Results: In 2113 transmissions from affected parents, there was a consistent parent-of-origin effect (P<0.001) with affected fathers having fewer affected daughters (20%, 95% CI 17–22%) than affected sons (25%, 95% CI 23–26%) or unaffected daughters (27%, 95% CI 25–30%). No discrepancies were observed between the RYR1 SNP genotypes recorded at the gDNA and cDNA levels. In 14 MH negative individuals from 11 discordant families, the familial mutation was detected in skeletal muscle cDNA in all cases.

Conclusions: Epigenetic allele silencing may play a role in the inheritance of MH susceptibility, but this is unlikely to involve silencing of RYR1.

Keywords: calcium channel block; complications, malignant hyperthermia; genetic factors, hyperthermia; muscle skeletal


{dagger} These authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.